[144] REGIS CORP SEC Filing

Rhea-AI Filing Summary

Form 144 notice for Regis Corp (RGS) shows a proposed sale of 937 common shares through Fidelity Brokerage Services with an aggregate market value of $26,719.50, to be sold approximately on 09/19/2025 on NASDAQ. The filing lists 2,435,981 shares outstanding for the class and indicates the securities were acquired under options granted on 05/05/2022 with payment in cash.

The filing also discloses that the same person previously sold 9,626 common shares on 09/18/2025 for gross proceeds of $278,342.53. The notice includes the standard signature representation that the seller is not aware of undisclosed material adverse information about the issuer.

Insights

Financial Analyst

TL;DR: Routine insider sale notice; transaction details are small and disclosed publicly.

The Form 144 documents a proposed public sale of 937 common shares by a person whose prior sale of 9,626 shares occurred one day earlier. The filing provides transaction specifics: broker, share counts, aggregate value, acquisition method (options granted 05/05/2022), and payment in cash. As a compliance disclosure, it informs investors of potential near-term share supply from an insider or affiliated holder but does not include operational, financial performance, or forward-looking details about the issuer.

Corporate Governance Expert

TL;DR: Disclosure meets Rule 144 notice requirements; contains required representations and transaction details.

The Form 144 furnishes the required information under Rule 144: identity of broker, number of shares offered, market value, acquisition source (options), and prior recent sales by the same person. The filing includes the attestation about absence of undisclosed material adverse information and the standard criminal-means warning, consistent with regulatory expectations for insider sales disclosures.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	937	26719.50	2435981	09/19/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	09/19/2025	Options Granted - 05/05/2022	Issuer			937	09/19/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Matthew Doctor 3701 Wayzata Boulevard Minneapolis MN 55416	Common	09/18/2025	9626	278342.53

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 for RGS disclose about the proposed sale?

The filing discloses a proposed sale of 937 common shares via Fidelity Brokerage, aggregate market value $26,719.50, to be sold on or about 09/19/2025 on NASDAQ.

Who conducted prior sales by the same person and what were the details?

The filing lists a prior sale by Matthew Doctor of 9,626 common shares on 09/18/2025 for gross proceeds of $278,342.53.

How were the shares being sold originally acquired according to the filing?

The securities to be sold were acquired under options granted on 05/05/2022, with the listed acquisition date for these shares as 09/19/2025 and payment to be cash.

On which exchange will the proposed sales occur?

The filing indicates the proposed sale of the 937 shares will occur on NASDAQ.

Does the Form 144 include any statement about undisclosed material information?

Yes. The signer represents by signing the notice that they do not know any material adverse information about the issuer that has not been publicly disclosed.